Annual Accounts Payable
$896.00 K
+$219.00 K+32.35%
December 31, 2023
Summary
- As of February 23, 2025, SYRE annual accounts payable is $896.00 thousand, with the most recent change of +$219.00 thousand (+32.35%) on December 31, 2023.
- During the last 3 years, SYRE annual accounts payable has fallen by -$1.36 million (-60.25%).
- SYRE annual accounts payable is now -73.00% below its all-time high of $3.32 million, reached on December 1, 2021.
Performance
SYRE Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$5.17 M
+$1.93 M+59.86%
September 30, 2024
Summary
- As of February 23, 2025, SYRE quarterly accounts payable is $5.17 million, with the most recent change of +$1.93 million (+59.86%) on September 30, 2024.
- Over the past year, SYRE quarterly accounts payable has stayed the same.
- SYRE quarterly accounts payable is now at all-time high.
Performance
SYRE Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
SYRE Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +32.4% | 0.0% |
| 3 y3 years | -60.3% | +23.6% |
| 5 y5 years | +35.1% | +23.6% |
SYRE Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -73.0% | +32.4% | at high | +662.9% |
| 5 y | 5-year | -73.0% | +32.4% | at high | +662.9% |
| alltime | all time | -73.0% | +433.3% | at high | +2974.4% |
Spyre Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $5.17 M(+59.9%) |
| Jun 2024 | - | $3.23 M(+4.0%) |
| Mar 2024 | - | $3.11 M(+246.7%) |
| Dec 2023 | $896.00 K(+32.3%) | $896.00 K(-46.6%) |
| Sep 2023 | - | $1.68 M(-41.2%) |
| Jun 2023 | - | $2.85 M(+38.4%) |
| Mar 2023 | - | $2.06 M(+204.6%) |
| Dec 2022 | $677.00 K(-79.6%) | - |
| Dec 2022 | - | $677.00 K(-83.8%) |
| Sep 2022 | - | $4.18 M(+113.4%) |
| Jun 2022 | - | $1.96 M(-34.3%) |
| Mar 2022 | - | $2.98 M(-10.2%) |
| Dec 2021 | $3.32 M(+47.2%) | $3.32 M(+78.2%) |
| Sep 2021 | - | $1.86 M(-16.1%) |
| Jun 2021 | - | $2.22 M(+18.3%) |
| Mar 2021 | - | $1.88 M(-16.7%) |
| Dec 2020 | $2.25 M(-28.5%) | $2.25 M(-1.8%) |
| Sep 2020 | - | $2.29 M(-44.7%) |
| Jun 2020 | - | $4.15 M(+14.7%) |
| Mar 2020 | - | $3.62 M(+14.7%) |
| Dec 2019 | $3.15 M | $3.15 M(+29.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $2.43 M(-10.8%) |
| Jun 2019 | - | $2.72 M(-15.5%) |
| Mar 2019 | - | $3.22 M(+386.1%) |
| Dec 2018 | $663.00 K(+70.4%) | $663.00 K(-38.4%) |
| Sep 2018 | - | $1.08 M(+13.1%) |
| Jun 2018 | - | $952.00 K(+24.8%) |
| Mar 2018 | - | $763.00 K(+96.1%) |
| Dec 2017 | $389.00 K(+131.5%) | $389.00 K(-36.7%) |
| Sep 2017 | - | $615.00 K(-3.0%) |
| Jun 2017 | - | $634.00 K(+137.5%) |
| Mar 2017 | - | $267.00 K(+58.9%) |
| Dec 2016 | $168.00 K(-4.5%) | $168.00 K(-67.9%) |
| Sep 2016 | - | $523.00 K(+50.3%) |
| Jun 2016 | - | $348.00 K(-31.6%) |
| Mar 2016 | - | $509.00 K(+189.2%) |
| Dec 2015 | $176.00 K(-49.0%) | $176.00 K(-68.7%) |
| Sep 2015 | - | $562.00 K(-49.3%) |
| Jun 2015 | - | $1.11 M(+282.4%) |
| Mar 2015 | - | $290.00 K(-15.9%) |
| Dec 2014 | $345.00 K(+59.0%) | $345.00 K |
| Dec 2013 | $217.00 K | - |
FAQ
- What is Spyre Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Spyre Therapeutics?
- What is Spyre Therapeutics annual accounts payable year-on-year change?
- What is Spyre Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Spyre Therapeutics?
- What is Spyre Therapeutics quarterly accounts payable year-on-year change?
What is Spyre Therapeutics annual accounts payable?
The current annual accounts payable of SYRE is $896.00 K
What is the all time high annual accounts payable for Spyre Therapeutics?
Spyre Therapeutics all-time high annual accounts payable is $3.32 M
What is Spyre Therapeutics annual accounts payable year-on-year change?
Over the past year, SYRE annual accounts payable has changed by +$219.00 K (+32.35%)
What is Spyre Therapeutics quarterly accounts payable?
The current quarterly accounts payable of SYRE is $5.17 M
What is the all time high quarterly accounts payable for Spyre Therapeutics?
Spyre Therapeutics all-time high quarterly accounts payable is $5.17 M
What is Spyre Therapeutics quarterly accounts payable year-on-year change?
Over the past year, SYRE quarterly accounts payable has changed by $0.00 (0.00%)